Publications by authors named "Maria H Gilleece"

Claim this Profile
L
Letermovir prophylaxis in T-cell-depleted transplants: breakthrough and rebound infections in the postmarketing setting.
Maria A V Marzolini, Varun Mehra, Kirsty J Thomson, Eleni Tholouli, Adrian J C Bloor, Maria H Gilleece

Blood Adv· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMT.
Maria H Gilleece, Avichai Shimoni, Myriam Labopin, Stephen Robinson, Dietrich Beelen

Blood Cancer J· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation.
Eolia Brissot, Myriam Labopin, Frédéric Baron, Ali Bazarbachi, Gesine Bug, Maria H Gilleece

Bone Marrow Transplant· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registry.
Roni Shouval, Joshua A Fein, Myriam Labopin, Christina Cho, Ali Bazarbachi, Maria H Gilleece

Lancet Haematol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurable residual disease (MRD) testing for acute leukemia in EBMT transplant centers: a survey on behalf of the ALWP of the EBMT.
Arnon Nagler, Frédéric Baron, Myriam Labopin, Emmanuel Polge, Jordi Esteve, Maria H Gilleece

Bone Marrow Transplant· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study.
Adrian J C Bloor, Amit Patel, James E Griffin, Maria H Gilleece, Rohini Radia

Nat Med· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A stitch in time saves nine… MRD-based pre-emptive therapy.
Maria H Gilleece, Bipin N Savani

Br J Haematol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic haemopoietic transplantation for acute myeloid leukaemia in second complete remission: a registry report by the Acute Leukaemia Working Party of the EBMT.
Maria H Gilleece, Myriam Labopin, Bipin N Savani, Ibrahim Yakoub-Agha, Gerard Socié

Leukemia· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurable residual disease, conditioning regimen intensity, and age predict outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first remission: A registry analysis of 2292 patients by the Acute Leukemia Working Party European Society of Blood and Marrow Transplantation.
Maria H Gilleece, Myriam Labopin, Ibrahim Yakoub-Agha, Liisa Volin, Gerard Socié

Am J Hematol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conditioning intensity in secondary AML with prior myelodysplastic syndrome/myeloproliferative disorders: an EBMT ALWP study.
Salyka Sengsayadeth, Katie S Gatwood, Ariane Boumendil, Myriam Labopin, Jürgen Finke, Maria H Gilleece

Blood Adv· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The outcome of haemopoietic stem cell transplantation in the treatment of lymphoplasmacytic lymphoma in the UK: a British Society Bone Marrow Transplantation study.
Maria H Gilleece, Rachel Pearce, David C Linch, Marie Wilson, Keiren Towlson

Hematology· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Taking the measure of alemtuzumab.
Maria H Gilleece

Leuk Res· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukaemia.
Maria H Gilleece, Francesco Dazzi

Leuk Lymphoma· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis